Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

AMBISOME NEWS ENCOURAGES COMPETITORS

Feb. 7, 1992

GENZYME DRUG GETS ORPHAN DESIGNATION

Feb. 7, 1992

BTG ACQUIRES POULTRY VACCINE TECHNOLOGY

Feb. 7, 1992

GENSIA SUBSIDIARY GETS NDA APPROVAL

Feb. 7, 1992

REGENERON ACQUIRES LICENSES FOR GMF

Feb. 6, 1992

APPLIED MICRO EXTENDS WARRANTS DEADLINE

Feb. 6, 1992

CLASS-ACTION SUIT AGAINST XYTRONYX

Feb. 6, 1992

GENETIC REGIONS THAT CAUSE MD

Feb. 6, 1992

IMMUNOMEDICS GETS SBIR

Feb. 6, 1992

VCS OPTIMISTIC ABOUT 1992

Feb. 6, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...